Industry Verticals »

All Categories

Insights »

About TMR »

Infectious Disease Diagnostics Market

Infectious Disease Diagnostics Market (By Product & Service: Reagents, Kits & Consumables, Instruments, Software & Services; By Type of Testing: Laboratory Testing, Point-of-Care Testing; By Sample Type: Blood, Serum & Plasma, Urine, Swab Samples, Stool, Others; By Technology: Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray, Others; By Disease Type: Hepatitis, HIV, Tuberculosis, Influenza, HPV, HAIs, Chlamydia, Gonorrhea, Syphilis, Others; and by End-user) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2026–2036

Infectious Disease Diagnostics Market Outlook 2036

The global infectious disease diagnostics market size was valued at USD 25.2 Billion in 2025 and is projected to reach USD 67.7 Billion by 2036, expanding at a CAGR of 9.4% from 2026 to 2036. Rising prevalence of infectious diseases is driving demand for reliable diagnostic solutions, as increasing cases of respiratory, bacterial, viral, and vector-borne infections require timely detection and effective disease management. Growing demand for rapid and accurate diagnostics is accelerating adoption of molecular, multiplex, and POC testing technologies, enabling faster pathogen identification & supporting early treatment decisions.

Infectious Disease Diagnostics Market Size and Highlights

  • The infectious disease diagnostics market reached USD 25.2 Billion in 2025.
  • The market is expected to reach USD 67.7 Billion by 2036.
  • The infectious disease diagnostics industry is anticipated to expand at a CAGR of 9.4% from 2026 to 2036.
  • Top players include Roche, Abbott, Danaher, bioMérieux, etc.
  • North America dominated the market in 2025, holding the largest revenue share of 38.2%.
  • By product & service, reagents, kits & consumables segment held the largest market share of 31.8% in 2025.

Infectious Disease Diagnostics Market By Revenue

Analysts’ Viewpoint on the Global Infectious Disease Diagnostics Market

The global infectious disease diagnostics market is steadily growing due to the increasing prevalence of respiratory diseases, HIV, tuberculosis, sexually transmitted diseases, and various other infectious diseases. Healthcare providers are also increasingly focusing on early and effective diagnosis, which has led to the adoption of molecular diagnostics, PCR testing, multiplex assays, rapid diagnostics, and point-of-care solutions for swift pathogen identification. Market growth is constrained by the high cost of advanced diagnostic instruments, limited reimbursement coverage, stringent regulatory requirements, and shortages of skilled laboratory professionals.

Differences in healthcare systems, laboratory abilities, and access to diagnostic technologies in developing countries may pose a further barrier to the implementation of advanced solutions. Asia Pacific, Latin America, and the Middle East & Africa are offer significant expansion opportunities due to improving healthcare infrastructure, increasing healthcare spending, infectious disease control programs by various governments, and improved awareness of early diagnosis. Portable molecular platforms, decentralized testing, home-based diagnostics, and AI-enabled solutions are expected to support further market penetration.

The market is witnessing a transition to technological advancements in rapid, decentralized, multiplex and molecular testing solutions, along with better integration with digital healthcare and laboratory information systems leading to improvements in diagnostic workflow. Growing interest in antimicrobial resistance, genomic surveillance, outbreak preparedness, and newly emerging pathogens will also contribute to the increase in the investments in next-generation diagnostic technologies.

Market Introduction

Infectious disease diagnostics refers to a range of laboratory and clinical testing methods used to detect, identify, and characterize pathogens such as bacteria, viruses, fungi, and parasites that cause infectious diseases. These diagnostics include molecular tests, immunoassays, antigen and antibody tests, culture-based methods, and rapid point-of-care tests, helping healthcare professionals confirm infections, guide treatment decisions, monitor disease progression, and support infection-control and surveillance programs.

Attribute Detail
Market Drivers
  • Rising prevalence of infectious diseases
  • Growing Demand for Early and Accurate Diagnosis

Rising prevalence of infectious diseases Expected to Drive Infectious Disease Diagnostics Market Size

The increase in the prevalence of infectious diseases all over the globe is projected to substantially contribute to the growth of the infectious disease testing market. This is due to the increasing number of cases of bacterial infections, viral infections, infections caused by fungi, and diseases caused by parasites that require quick identification of the disease and effective identification of the pathogen. Infectious diseases include diseases like respiratory infections and tuberculosis and this causes a burden on the healthcare systems. When there are more infected individuals, the healthcare personnel look for tests that can quickly make the diagnosis confirmed and know the cause of the disease in the confirmed cases.

The emergence of diseases again and again is making the demand for making rapid and specific tests bigger. The technologies that are being implemented allow the physician to make the diagnoses quickly. In addition, the growing knowledge of infectious disease prevention and early diagnosis as well as the expanding healthcare systems and diagnostic facilities will lead to higher volumes of testing in developing nations. Increased investments in disease monitoring and preparations for outbreaks also lead to advanced diagnostics methods being adopted. As a result, the demand for tests, equipment, and other services in the field will increase due to the rising global burden of infectious diseases.

Growing Demand for Early and Accurate Diagnosis Supports Market Expansion

Growing demand for timely and accurate pathogen detection is expected to support expansion of the global infectious disease diagnostics market. Timely identifications allow clinicians to offer proper treatment quickly, reduce disease transmission, as well as improve patient outcomes. The rising prevalence rate of respiratory infections, tuberculosis, HIV, hepatitis, sexually transmitted diseases, gastrointestinal infections, and other infectious diseases only adds to the demand for reliable diagnostic solutions.

Healthcare systems start putting more emphasis on fast and accurate diagnostics in order to minimize the time it takes to make a diagnosis and make the right evidence-based medical decisions. As a result, the adoption of molecular diagnostics, PCR assays, multiplex testing, immunoassays, rapid antigen tests, and point-of-care technologies is increasing, which are known for their improved sensitivity and specificity in comparison to conventional methods. The growing concern regarding antimicrobial resistance (AMR) highlights the need for accurate pathogen identification. Fast diagnostic tests may assist doctors in differentiating bacterial and viral infections, thus ensuring the proper use of antimicrobials and lowering unnecessary antibiotic prescription rates. With the increase in expenditure on infectious disease monitoring and outbreak readiness, the amount of conducted diagnostic tests increases. The transition to decentralized and near-patient testing allows obtaining timely results, especially in areas where patients lack sufficient medical attention. Continuous development of technology and growing focus on early detection of diseases are likely to sustain the demand for high-quality diagnostic solutions in the area of infectious diseases.

Attribute Detail
Market Opportunity

Growing adoption of point-of-care diagnostics Expected to Create Opportunities for the Infectious Disease Diagnostics Market

The increase in the use of POC testing is predicted to offer a number of opportunities to the global infectious disease diagnostics market during the forecast period. Point-of-care testing enables infections to be diagnosed near the patient across hospitals, physicians’ offices, urgent care centres, pharmacies, community health centres, and other decentralized healthcare settings. The ability to receive test results within minutes or hours will allow fast clinical decisions to be made by doctors, which will facilitate diagnosis and treatment in case there is no need to wait for conventional laboratory test results.

The need for quick diagnosis of respiratory infections, sexually transmitted infections, gastrointestinal infections, and other infectious diseases pushes the healthcare professionals to use portable diagnostic devices that are simple to operate. The attention to molecular POC technologies grows as well since they provide the possibility for decentralized testing. POC diagnostics also offer substantial potential in resource-limited and remote settings, where access to centralized laboratories may be limited. Expanding healthcare infrastructure across emerging economies is therefore expected to create additional demand for portable infectious disease testing solutions. Growing concerns regarding antimicrobial resistance are increasing the importance of rapid pathogen detection and treatment guidance at the point of care.

Technological advancements such as multiplex testing, cartridge-based systems, automation, connectivity, and AI-enabled diagnostic interpretation are further enhancing POC capabilities. As healthcare systems increasingly prioritize faster diagnosis, decentralized care, and improved accessibility, the continued expansion of POC diagnostics is expected to create new growth opportunities for infectious disease diagnostic manufacturers and technology providers.

Reagents, Kits & Consumables Driving Infectious Disease Diagnostics Market Growth

Infectious Disease Diagnostics Market By Type

The reagents, kits and consumables segment dominated the global infectious disease diagnostics market in 2025, accounting for approximately 31.8% of total market revenue. This is due to the ongoing need for diagnostic testing in healthcare facilities, laboratories, research institutions, and healthcare settings, unlike instruments, which are generally purchased less frequently, reagents and consumables require continuous replenishment. Recurring purchases of diagnostic reagents, test kits, cartridges, test panels, specimen collection devices, and any other reagents and consumables is responsible for generating a recurring revenue for the stakeholders.

There is also a growing incidence of infectious diseases which results in an increased demand for routine and confirmatory testing frequently. The widespread use of molecular diagnostics, PCR-based testing, immunoassays, and multiplex testing is leading to an increase in the use of distinctive reagents and testing kits. The shift toward rapid and decentralized testing is another important factor supporting segment growth. Diagnostic point-of-care platforms depend on the use of consumables, which guarantees continuing demand for these consumable items. Advances in technology have allowed for the emergence of more sophisticated, accurate and multi-purpose testing kits, which are capable of testing for several diseases at once. The fact that testing is done at high volume and that there is a need for recurring replacement of consumables, and that there is an increasing prevalence of infectious diseases and improvements in technology, is expected to ensure the leadership of reagents, kits & consumables segment in the infectious disease diagnostics market.

Regional Outlook of Infectious Disease Diagnostics Market

Infectious Disease Diagnostics Market By Region

Attribute Detail
Leading Region
  • North America

North America dominated the global infectious disease diagnostics market in 2025, accounting for approximately 38.2% of total market revenue. North America is expected to dominate the global market, supported by advanced healthcare infrastructure, high diagnostic testing volumes, and strong adoption of innovative diagnostic technologies. The region possesses a developed network of hospitals, clinical laboratories, research centers, and diagnostic networks which provide opportunities for the wide consumption of technologies for molecular diagnostics, immunoassays, PCR testing, and rapid diagnostics at the point of care.

The U.S. accounts for a substantial share of the regional market due to high healthcare expenditure, a large network of diagnostic laboratories, and the presence of leading diagnostic companies. High awareness of the importance of rapid infectious disease diagnosis is also supporting demand for advanced diagnostic solutions. The region has a robust ecosystem for research and development that promotes the invention and commercialization of next-generation diagnostic technologies such as multiplex molecular assays, syndromic testing platforms, and automated diagnosis systems. The ongoing monitoring of new and re-emerging infectious diseases raises the demand for effective diagnostics.

Increasing use of point-of-care and decentralized testing is another driver of market growth, which is most pronounced in the emergency departments, physicians’ offices and outpatient facilities. Favorable reimbursement conditions and increasing investments in healthcare infrastructure help the introduction of diagnostics into practice. The combination of developed healthcare infrastructure, abundant demand for diagnostics, innovation in technology, strong R&D capacity, and high healthcare expenditure will allow the region to remain in the lead in the infectious disease diagnostics market.

Analysis of Key Players in Infectious Disease Diagnostics Market

F. Hoffmann-La Roche Ltd., Abbott, Danaher Corporation, bioMérieux, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Becton, Dickinson and Company (BD), QIAGEN N.V., Hologic, Inc., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., QuidelOrtho Corporation, Revvity, Inc., Grifols S.A., and Sysmex Corporation are among the prominent players operating in the global infectious disease diagnostics market. Each of these players has been profiled in the market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments

  • In August 2026, QIAGEN announced that the U.S. Food and Drug Administration (FDA) has cleared the QIAstat-Dx BCID GPF Plus AMR Panel, the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance. The QIAstat-Dx BCID GPF Plus AMR Panel detects 20 gram-positive bacterial and fungal pathogen targets as well as a broad pan gram-negative target together with 10 genetic antimicrobial resistance markers from positive blood culture samples in about one hour.
  • In July 2026, Roche announced that its Elecsys IGRA TB test received the CE Mark, introducing a new blood testing solution for identifying tuberculosis infection (TBI, also known as latent TB) in routine laboratory settings. The new solution enables fast, simple, and efficient diagnosis, and can provide results in under 24 hours.
  • In February 2026, MedGenome has announced the launch of MetaSeq, an advanced blood test designed to support faster and more comprehensive detection of bloodstream infections (BSI). MetaSeq uses metagenomic next-generation sequencing (NGS) to analyse microbial cell-free DNA (cfDNA) present in the bloodstream.

Infectious Disease Diagnostics Market Snapshot

Attribute Detail
Size in 2025 USD 25.2 Billion
Forecast Value in 2036 USD 67.7 Billion
CAGR 9.4%
Forecast Period 2026-2036
Historical Data Available for 2021-2025
Quantitative Units USD Billion for Value
Market Analysis It includes segment analysis as well as regional level analysis. Qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape
  • Competition Matrix
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Segmentation By Product & Service
  • Reagents, Kits & Consumables
  • Instruments
  • Software & Services
By Type of Testing
  • Laboratory Testing
  • Point-of-Care (POC) Testing
By Sample Type
  • Blood, Serum & Plasma
  • Urine
  • Swab Samples
  • Stool
  • Others
By Technology
  • Immunodiagnostics
  • Clinical Microbiology
  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • DNA Sequencing & Next-Generation Sequencing (NGS)
  • DNA Microarray
  • Others
By Disease Type
  • Hepatitis
  • HIV
  • Tuberculosis
  • Influenza
  • HPV
  • Hospital-Acquired Infections (HAIs)
  • Chlamydia
  • Gonorrhea
  • Syphilis
  • Others
By End User
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Public Health Laboratories
  • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • The Netherlands
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Brazil
  • Mexico
  • Argentina
  • GCC Countries
  • South Africa
Companies Profiled
  • F. Hoffmann-La Roche Ltd.
  • Abbott
  • Danaher Corporation
  • bioMérieux
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Becton, Dickinson and Company (BD)
  • QIAGEN N.V.
  • Hologic, Inc.
  • Bio-Rad Laboratories, Inc.
  • DiaSorin S.p.A.
  • QuidelOrtho Corporation
  • Revvity, Inc.
  • Grifols S.A.
  • Sysmex Corporation
  • Others
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global infectious disease diagnostics market in 2025?

The market was valued at USD 25.2 Billion in 2025.

What is the projected size of the infectious disease diagnostics industry by 2036?

The industry is projected to reach USD 67.7 Billion by 2036.

What are the factors driving the infectious disease diagnostics market?

Rising prevalence of infectious diseases and growing demand for early and accurate diagnosis.

What will be the CAGR of the global infectious disease diagnostics market during the forecast period?

The market is anticipated to expand at a CAGR of 9.4% from 2026 to 2036.

Which region is expected to dominate the infectious disease diagnostics market during the forecast period?

North America is expected to account for the largest market share from 2026 to 2036.

Who are the prominent players in the global infectious disease diagnostics market?

F. Hoffmann-La Roche Ltd., Abbott, Danaher Corporation, bioMérieux, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Becton, Dickinson and Company (BD), QIAGEN N.V., Hologic, Inc., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., QuidelOrtho Corporation, Revvity, Inc., Grifols S.A., and Sysmex Corporation among others.

  1. Preface
    • Market Definition and Scope
    • Market Segmentation
    • Key Research Objectives
    • Research Highlights
  2. Assumptions and Research Methodology
  3. Executive Summary: Global Infectious Disease Diagnostics Market
  4. Market Overview
    • Introduction
      • Segment Definition
      • Industry Evolution / Developments
    • Overview
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Global Infectious Disease Diagnostics Market Analysis and Forecast, 2021-2036
      • Market Revenue Projections (USD Billion)
  5. Key Insights
    • Regulatory Scenario by Country/Region
    • Technological Advancements
    • Porter’s Five Forces Analysis
    • PESTLE Analysis
    • Key Industry Events
    • Molecular Diagnostics Adoption
    • Healthcare Infrastructure Development
    • Disease Epidemiology & Burden
    • Supply Chain & Manufacturing Trends
    • Brand and Pricing Analysis
  6. Global Infectious Disease Diagnostics Market Analysis and Forecast, by Product & Service
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Attractiveness Analysis, by Product & Service
  7. Global Infectious Disease Diagnostics Market Analysis and Forecast, by Type of Testing
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Attractiveness Analysis, by Type of Testing
  8. Global Infectious Disease Diagnostics Market Analysis and Forecast, by Sample Type
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Attractiveness Analysis, by Sample Type
  9. Global Infectious Disease Diagnostics Market Analysis and Forecast, by Technology
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Attractiveness Analysis, by Technology
  10. Global Infectious Disease Diagnostics Market Analysis and Forecast, by Disease Type
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Attractiveness Analysis, by Disease Type
  11. Global Infectious Disease Diagnostics Market Analysis and Forecast, by End User
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis, by End User
  12. Global Infectious Disease Diagnostics Market Analysis and Forecast, by Region
    • Key Findings
    • Market Value Forecast, by Region, 2021-2036
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
    • Market Attractiveness Analysis, by Region
  13. North America Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • U.S.
      • Canada
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
      • By Country/Sub-region
  14. U.S. Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  15. Canada Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  16. Europe Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • The Netherlands
      • Switzerland
      • Rest of Europe
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
      • By Country/Sub-region
  17. Germany Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  18. United Kingdom Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  19. France Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  20. Italy Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  21. Spain Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  22. The Netherlands Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  23. Switzerland Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  24. Rest of Europe Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  25. Asia Pacific Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • China
      • India
      • Japan
      • South Korea
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
      • By Country/Sub-region
  26. China Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  27. India Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  28. Japan Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  29. South Korea Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  30. Australia & New Zealand Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  31. Rest of Asia Pacific Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  32. Latin America Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
      • By Country/Sub-region
  33. Brazil Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  34. Mexico Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  35. Argentina Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  36. Rest of Latin America Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  37. Middle East & Africa Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
      • By Country/Sub-region
  38. GCC Countries Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  39. South Africa Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  40. Rest of Middle East & Africa Infectious Disease Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product & Service, 2021-2036
      • Reagents, Kits & Consumables
      • Instruments
      • Software & Services
    • Market Value Forecast, by Type of Testing, 2021-2036
      • Laboratory Testing
      • Point-of-Care (POC) Testing
    • Market Value Forecast, by Sample Type, 2021-2036
      • Blood, Serum & Plasma
      • Urine
      • Swab Samples
      • Stool
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Immunodiagnostics
      • Clinical Microbiology
      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • DNA Microarray
      • Others
    • Market Value Forecast, by Disease Type, 2021-2036
      • Hepatitis
      • HIV
      • Tuberculosis
      • Influenza
      • HPV
      • Hospital-Acquired Infections (HAIs)
      • Chlamydia
      • Gonorrhea
      • Syphilis
      • Others
    • Market Value Forecast, by End User, 2021-2036
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Public Health Laboratories
      • Others
    • Market Attractiveness Analysis
      • By Product & Service
      • By Type of Testing
      • By Sample Type
      • By Technology
      • By Disease Type
      • By End User
  41. Competition Landscape
    • Market Player - Competition Matrix (By Tier and Size of Companies)
    • Market Share Analysis, by Company (2025)
    • Company Profiles
      • F. Hoffmann-La Roche Ltd.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Abbott
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Danaher Corporation
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • bioMérieux
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Thermo Fisher Scientific Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Siemens Healthineers AG
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Becton, Dickinson and Company (BD)
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • QIAGEN N.V.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Hologic, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • DiaSorin S.p.A.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • QuidelOrtho Corporation
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Revvity, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Grifols S.A.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Sysmex Corporation
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments

List of Tables

Table 01: Global Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 02: Global Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 03: Global Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 04: Global Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 05: Global Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 06: Global Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 07: Global Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 08: North America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 09: North America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 10: North America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 11: North America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 12: North America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 13: North America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 14: North America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 15: U.S. Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 16: U.S. Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 17: U.S. Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 18: U.S. Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 19: U.S. Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 20: U.S. Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 21: Canada Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 22: Canada Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 23: Canada Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 24: Canada Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 25: Canada Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 26: Canada Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 27: Europe Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 28: Europe Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 29: Europe Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 30: Europe Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 31: Europe Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 32: Europe Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 33: Europe Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 34: Germany Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 35: Germany Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 36: Germany Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 37: Germany Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 38: Germany Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 39: Germany Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 40: U.K. Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 41: U.K. Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 42: U.K. Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 43: U.K. Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 44: U.K. Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 45: U.K. Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 46: France Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 47: France Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 48: France Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 49: France Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 50: France Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 51: France Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 52: Italy Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 53: Italy Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 54: Italy Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 55: Italy Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 56: Italy Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 57: Italy Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 58: Spain Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 59: Spain Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 60: Spain Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 61: Spain Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 62: Spain Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 63: Spain Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 64: Switzerland Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 65: Switzerland Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 66: Switzerland Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 67: Switzerland Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 68: Switzerland Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 69: Switzerland Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 70: The Netherlands Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 71: The Netherlands Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 72: The Netherlands Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 73: The Netherlands Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 74: The Netherlands Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 75: The Netherlands Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 76: Rest of Europe Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 77: Rest of Europe Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 78: Rest of Europe Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 79: Rest of Europe Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 80: Rest of Europe Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 81: Rest of Europe Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 82: Asia Pacific Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 83: Asia Pacific Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 84: Asia Pacific Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 85: Asia Pacific Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 86: Asia Pacific Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 87: Asia Pacific Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 88: Asia Pacific Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 89: China Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 90: China Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 91: China Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 92: China Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 93: China Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 94: China Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 95: Japan Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 96: Japan Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 97: Japan Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 98: Japan Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 99: Japan Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 100: Japan Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 101: India Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 102: India Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 103: India Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 104: India Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 105: India Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 106: India Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 107: South Korea Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 108: South Korea Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 109: South Korea Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 110: South Korea Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 111: South Korea Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 112: South Korea Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 113: Australia and New Zealand Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 114: Australia and New Zealand Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 115: Australia and New Zealand Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 116: Australia and New Zealand Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 117: Australia and New Zealand Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 118: Australia and New Zealand Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 119: Rest of Asia Pacific Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 120: Rest of Asia Pacific Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 121: Rest of Asia Pacific Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 122: Rest of Asia Pacific Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 123: Rest of Asia Pacific Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 124: Rest of Asia Pacific Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 125: Latin America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 126: Latin America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 127: Latin America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 128: Latin America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 129: Latin America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 130: Latin America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 131: Latin America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 132: Brazil Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 133: Brazil Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 134: Brazil Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 135: Brazil Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 136: Brazil Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 137: Brazil Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 138: Mexico Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 139: Mexico Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 140: Mexico Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 141: Mexico Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 142: Mexico Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 143: Mexico Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 144: Argentina Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 145: Argentina Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 146: Argentina Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 147: Argentina Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 148: Argentina Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 149: Argentina Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 150: Rest of Latin America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 151: Rest of Latin America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 152: Rest of Latin America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 153: Rest of Latin America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 154: Rest of Latin America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 155: Rest of Latin America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 156: Middle East and Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 157: Middle East and Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 158: Middle East and Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 159: Middle East and Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 160: Middle East and Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 161: Middle East and Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 162: Middle East and Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 163: GCC Countries Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 164: GCC Countries Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 165: GCC Countries Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 166: GCC Countries Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 167: GCC Countries Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 168: GCC Countries Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 169: South Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 170: South Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 171: South Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 172: South Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 173: South Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 174: South Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036
Table 175: Rest of Middle East and Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Product & Service, 2021 to 2036
Table 176: Rest of Middle East and Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Type of Testing, 2021 to 2036
Table 177: Rest of Middle East and Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Sample Type, 2021 to 2036
Table 178: Rest of Middle East and Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Technology, 2021 to 2036
Table 179: Rest of Middle East and Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by Disease Type, 2021 to 2036
Table 180: Rest of Middle East and Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, by End User, 2021 to 2036

List of Figures

Figure 01: Global Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 02: Global Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 03: Global Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 04: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Reagents, Kits & Consumables, 2021 to 2036
Figure 05: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Instruments, 2021 to 2036
Figure 06: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Software & Services, 2021 to 2036
Figure 07: Global Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 08: Global Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 09: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Laboratory Testing, 2021 to 2036
Figure 10: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Point-of-Care (POC) Testing, 2021 to 2036
Figure 11: Global Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 12: Global Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 13: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Blood, Serum & Plasma, 2021 to 2036
Figure 14: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Urine, 2021 to 2036
Figure 15: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Swab Samples, 2021 to 2036
Figure 16: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Stool, 2021 to 2036
Figure 17: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Others, 2021 to 2036
Figure 18: Global Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 19: Global Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 20: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Immunodiagnostics, 2021 to 2036
Figure 21: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Clinical Microbiology, 2021 to 2036
Figure 22: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Polymerase Chain Reaction (PCR), 2021 to 2036
Figure 23: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Isothermal Nucleic Acid Amplification Technology (INAAT), 2021 to 2036
Figure 24: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by DNA Sequencing & Next-Generation Sequencing (NGS), 2021 to 2036
Figure 25: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by DNA Microarray, 2021 to 2036
Figure 26: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Others, 2021 to 2036
Figure 27: Global Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 28: Global Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 29: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Hepatitis, 2021 to 2036
Figure 30: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by HIV, 2021 to 2036
Figure 31: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Tuberculosis, 2021 to 2036
Figure 32: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Influenza, 2021 to 2036
Figure 33: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by HPV, 2021 to 2036
Figure 34: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Hospital-Acquired Infections (HAIs), 2021 to 2036
Figure 35: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Chlamydia, 2021 to 2036
Figure 36: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Gonorrhea, 2021 to 2036
Figure 37: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Syphilis3Others, 2021 to 2036
Figure 38: Global Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 39: Global Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 40: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Hospitals & Clinics, 2021 to 2036
Figure 41: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Diagnostic Laboratories, 2021 to 2036
Figure 42: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Academic & Research Institutes, 2021 to 2036
Figure 43: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Public Health Laboratories, 2021 to 2036
Figure 44: Global Infectious Disease Diagnostics Market Revenue (USD Billion), by Others, 2021 to 2036
Figure 45: Global Infectious Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 46: Global Infectious Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 47: North America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 48: North America Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 49: North America Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 50: North America Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 51: North America Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 52: North America Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 53: North America Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 54: North America Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 55: North America Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 56: North America Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 57: North America Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 58: North America Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 59: North America Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 60: North America Infectious Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 61: North America Infectious Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 62: U.S. Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 63: U.S. Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 64: U.S. Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 65: U.S. Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 66: U.S. Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 67: U.S. Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 68: U.S. Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 69: U.S. Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 70: U.S. Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 71: U.S. Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 72: U.S. Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 73: U.S. Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 74: U.S. Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 75: Canada Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 76: Canada Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 77: Canada Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 78: Canada Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 79: Canada Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 80: Canada Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 81: Canada Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 82: Canada Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 83: Canada Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 84: Canada Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 85: Canada Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 86: Canada Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 87: Canada Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 88: Europe Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 89: Europe Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 90: Europe Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 91: Europe Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 92: Europe Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 93: Europe Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 94: Europe Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 95: Europe Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 96: Europe Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 97: Europe Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 98: Europe Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 99: Europe Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 100: Europe Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 101: Europe Infectious Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 102: Europe Infectious Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 103: Germany Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 104: Germany Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 105: Germany Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 106: Germany Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 107: Germany Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 108: Germany Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 109: Germany Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 110: Germany Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 111: Germany Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 112: Germany Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 113: Germany Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 114: Germany Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 115: Germany Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 116: U.K. Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 117: U.K. Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 118: U.K. Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 119: U.K. Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 120: U.K. Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 121: U.K. Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 122: U.K. Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 123: U.K. Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 124: U.K. Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 125: U.K. Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 126: U.K. Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 127: U.K. Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 128: U.K. Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 129: France Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 130: France Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 131: France Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 132: France Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 133: France Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 134: France Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 135: France Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 136: France Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 137: France Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 138: France Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 139: France Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 140: France Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 141: France Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 142: Italy Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 143: Italy Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 144: Italy Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 145: Italy Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 146: Italy Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 147: Italy Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 148: Italy Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 149: Italy Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 150: Italy Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 151: Italy Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 152: Italy Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 153: Italy Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 154: Italy Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 155: Spain Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 156: Spain Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 157: Spain Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 158: Spain Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 159: Spain Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 160: Spain Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 161: Spain Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 162: Spain Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 163: Spain Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 164: Spain Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 165: Spain Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 166: Spain Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 167: Spain Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 168: Switzerland Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 169: Switzerland Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 170: Switzerland Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 171: Switzerland Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 172: Switzerland Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 173: Switzerland Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 174: Switzerland Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 175: Switzerland Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 176: Switzerland Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 177: Switzerland Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 178: Switzerland Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 179: Switzerland Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 180: Switzerland Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 181: The Netherlands Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 182: The Netherlands Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 183: The Netherlands Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 184: The Netherlands Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 185: The Netherlands Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 186: The Netherlands Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 187: The Netherlands Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 188: The Netherlands Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 189: The Netherlands Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 190: The Netherlands Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 191: The Netherlands Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 192: The Netherlands Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 193: The Netherlands Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 194: Rest of Europe Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 195: Rest of Europe Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 196: Rest of Europe Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 197: Rest of Europe Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 198: Rest of Europe Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 199: Rest of Europe Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 200: Rest of Europe Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 201: Rest of Europe Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 202: Rest of Europe Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 203: Rest of Europe Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 204: Rest of Europe Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 205: Rest of Europe Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 206: Rest of Europe Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 207: Asia Pacific Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 208: Asia Pacific Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 209: Asia Pacific Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 210: Asia Pacific Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 211: Asia Pacific Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 212: Asia Pacific Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 213: Asia Pacific Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 214: Asia Pacific Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 215: Asia Pacific Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 216: Asia Pacific Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 217: Asia Pacific Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 218: Asia Pacific Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 219: Asia Pacific Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 220: Asia Pacific Infectious Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 221: Asia Pacific Infectious Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 222: China Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 223: China Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 224: China Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 225: China Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 226: China Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 227: China Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 228: China Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 229: China Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 230: China Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 231: China Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 232: China Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 233: China Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 234: China Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 235: Japan Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 236: Japan Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 237: Japan Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 238: Japan Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 239: Japan Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 240: Japan Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 241: Japan Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 242: Japan Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 243: Japan Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 244: Japan Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 245: Japan Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 246: Japan Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 247: Japan Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 248: India Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 249: India Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 250: India Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 251: India Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 252: India Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 253: India Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 254: India Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 255: India Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 256: India Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 257: India Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 258: India Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 259: India Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 260: India Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 261: South Korea Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 262: South Korea Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 263: South Korea Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 264: South Korea Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 265: South Korea Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 266: South Korea Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 267: South Korea Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 268: South Korea Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 269: South Korea Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 270: South Korea Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 271: South Korea Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 272: South Korea Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 273: South Korea Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 274: Australia and New Zealand Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 275: Australia and New Zealand Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 276: Australia and New Zealand Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 277: Australia and New Zealand Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 278: Australia and New Zealand Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 279: Australia and New Zealand Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 280: Australia and New Zealand Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 281: Australia and New Zealand Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 282: Australia and New Zealand Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 283: Australia and New Zealand Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 284: Australia and New Zealand Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 285: Australia and New Zealand Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 286: Australia and New Zealand Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 287: Rest of Asia Pacific Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 288: Rest of Asia Pacific Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 289: Rest of Asia Pacific Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 290: Rest of Asia Pacific Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 291: Rest of Asia Pacific Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 292: Rest of Asia Pacific Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 293: Rest of Asia Pacific Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 294: Rest of Asia Pacific Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 295: Rest of Asia Pacific Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 296: Rest of Asia Pacific Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 297: Rest of Asia Pacific Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 298: Rest of Asia Pacific Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 299: Rest of Asia Pacific Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 300: Latin America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 301: Latin America Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 302: Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 303: Latin America Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 304: Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 305: Latin America Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 306: Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 307: Latin America Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 308: Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 309: Latin America Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 310: Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 311: Latin America Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 312: Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 313: Latin America Infectious Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 314: Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 315: Brazil Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 316: Brazil Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 317: Brazil Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 318: Brazil Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 319: Brazil Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 320: Brazil Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 321: Brazil Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 322: Brazil Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 323: Brazil Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 324: Brazil Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 325: Brazil Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 326: Brazil Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 327: Brazil Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 328: Mexico Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 329: Mexico Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 330: Mexico Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 331: Mexico Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 332: Mexico Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 333: Mexico Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 334: Mexico Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 335: Mexico Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 336: Mexico Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 337: Mexico Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 338: Mexico Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 339: Mexico Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 340: Mexico Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 341: Argentina Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 342: Argentina Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 343: Argentina Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 344: Argentina Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 345: Argentina Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 346: Argentina Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 347: Argentina Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 348: Argentina Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 349: Argentina Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 350: Argentina Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 351: Argentina Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 352: Argentina Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 353: Argentina Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 354: Rest of Latin America Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 355: Rest of Latin America Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 356: Rest of Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 357: Rest of Latin America Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 358: Rest of Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 359: Rest of Latin America Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 360: Rest of Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 361: Rest of Latin America Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 362: Rest of Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 363: Rest of Latin America Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 364: Rest of Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 365: Rest of Latin America Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 366: Rest of Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 367: Middle East and Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 368: Middle East and Africa Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 369: Middle East and Africa Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 370: Middle East and Africa Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 371: Middle East and Africa Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 372: Middle East and Africa Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 373: Middle East and Africa Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 374: Middle East and Africa Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 375: Middle East and Africa Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 376: Middle East and Africa Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 377: Middle East and Africa Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 378: Middle East and Africa Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 379: Middle East and Africa Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 380: Middle East and Africa Infectious Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 381: Middle East and Africa Infectious Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 382: GCC Countries Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 383: GCC Countries Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 384: GCC Countries Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 385: GCC Countries Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 386: GCC Countries Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 387: GCC Countries Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 388: GCC Countries Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 389: GCC Countries Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 390: GCC Countries Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 391: GCC Countries Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 392: GCC Countries Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 393: GCC Countries Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 394: GCC Countries Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 395: South Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 396: South Africa Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 397: South Africa Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 398: South Africa Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 399: South Africa Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 400: South Africa Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 401: South Africa Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 402: South Africa Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 403: South Africa Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 404: South Africa Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 405: South Africa Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 406: South Africa Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 407: South Africa Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036
Figure 408: Rest of Middle East and Africa Infectious Disease Diagnostics Market Value (USD Billion) Forecast, 2021 to 2036
Figure 409: Rest of Middle East and Africa Infectious Disease Diagnostics Market Value Share Analysis, by Product & Service, 2025 and 2036
Figure 410: Rest of Middle East and Africa Infectious Disease Diagnostics Market Attractiveness Analysis, by Product & Service, 2026 to 2036
Figure 411: Rest of Middle East and Africa Infectious Disease Diagnostics Market Value Share Analysis, by Type of Testing, 2025 and 2036
Figure 412: Rest of Middle East and Africa Infectious Disease Diagnostics Market Attractiveness Analysis, by Type of Testing, 2026 to 2036
Figure 413: Rest of Middle East and Africa Infectious Disease Diagnostics Market Value Share Analysis, by Sample Type, 2025 and 2036
Figure 414: Rest of Middle East and Africa Infectious Disease Diagnostics Market Attractiveness Analysis, by Sample Type, 2026 to 2036
Figure 415: Rest of Middle East and Africa Infectious Disease Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 416: Rest of Middle East and Africa Infectious Disease Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 417: Rest of Middle East and Africa Infectious Disease Diagnostics Market Value Share Analysis, by Disease Type, 2025 and 2036
Figure 418: Rest of Middle East and Africa Infectious Disease Diagnostics Market Attractiveness Analysis, by Disease Type, 2026 to 2036
Figure 419: Rest of Middle East and Africa Infectious Disease Diagnostics Market Value Share Analysis, by End User, 2025 and 2036
Figure 420: Rest of Middle East and Africa Infectious Disease Diagnostics Market Attractiveness Analysis, by End User, 2026 to 2036

Copyright © Transparency Market Research, Inc. All Rights reserved

Infectious Disease Diagnostics Market

Buy This ReportBuy Now